Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CPAP in Diabetic Nephropathy and OSA
NCT02816762Phase 4Completed
- Sponsor
- Hospital Universitario La Paz
- Start
- Jun 2016
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by Hospital Universitario La Paz. Primary endpoint: Change from baseline in albuminuria levels at 12 months. Started Jun 2016; status: completed.
Beyond the preview
Go deeper on NCT02816762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02816762.